{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:09:32Z","timestamp":1790064572249,"version":"4.0.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>HIV-1 Gag proteins are essential for virion assembly and viral replication in newly infected cells. Gag proteins are also strong determinants of viral infectivity; immune escape mutations in the Gag capsid (CA) protein can markedly reduce viral fitness, and interactions of CA with host proteins such as cyclophilin A (CypA) and TRIM5\u03b1 can have important effects on viral infectivity. Little information, however, is available concerning the extent that different primary Gag proteins affect HIV-1 replication in different cell types, or the impact on viral replication of differences in the expression by target cells of proteins that interact with CA. To address these questions, we compared the infectivity of recombinant HIV-1 viruses expressing Gag-protease sequences from primary isolates in different target cells in the presence or absence of agents that disrupt cyclophilin A \u2013 CA interactions and correlated these results with the viral genotype and the expression of cyclophilin A and TRIM5\u03b1 by the target cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Viral infectivity was governed by the nature of the Gag proteins in a target cell-specific fashion. The treatment of target cells with agents that disrupt CypA-CA interactions often produced biphasic dose-response curves in which viral infectivity first increased and subsequently decreased as a function of the dose used. The extent that treatment of target cells with high-dose CypA inhibitors impaired viral infectivity was dependent on several factors, including the viral genotype, the nature of the target cell, and the extent that treatment with low-dose CypA inhibitors increased viral infectivity. Neither the presence of polymorphisms in the CA CypA-binding loop, the level of expression of CypA, or the level of TRIM5\u03b1 expression could, alone, explain the differences in the shape of the dose-response curves observed or the extent that high-dose CypA inhibitors reduced viral infectivity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Multiple interactions between host-cell factors and Gag can strongly affect HIV-1 infectivity, and these vary according to target cell type and the origin of the Gag sequence. Two of the cellular activities involved appear to be modulated in opposite directions by CypA-CA interactions, and Gag sequences determine the intrinsic sensitivity of a given virus to each of these cellular activities.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1742-4690-6-21","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T07:13:32Z","timestamp":1236064412000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type"],"prefix":"10.1186","volume":"6","author":[{"given":"Saori","family":"Matsuoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Dam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Lecossier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Clavel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan J","family":"Hance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,2]]},"reference":[{"issue":"4","key":"1026_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrmicro1541","volume":"5","author":"SP Goff","year":"2007","unstructured":"Goff SP: Host factors exploited by retroviruses. Nat Rev Microbiol. 2007, 5 (4): 253-263. 10.1038\/nrmicro1541.","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"1026_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nrmicro1579","volume":"5","author":"Y Suzuki","year":"2007","unstructured":"Suzuki Y, Craigie R: The road to chromatin \u2013 nuclear entry of retroviruses. Nat Rev Microbiol. 2007, 5 (3): 187-196. 10.1038\/nrmicro1579.","journal-title":"Nat Rev Microbiol"},{"key":"1026_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1742-4690-1-9","volume":"1","author":"S Nisole","year":"2004","unstructured":"Nisole S, Saib A: Early steps of retrovirus replicative cycle. Retrovirology. 2004, 1: 9-10.1186\/1742-4690-1-9.","journal-title":"Retrovirology"},{"issue":"3","key":"1026_CR4","first-page":"150","volume":"9","author":"KC Klein","year":"2007","unstructured":"Klein KC, Reed JC, Lingappa JR: Intracellular destinies: degradation, targeting, assembly, and endocytosis of HIV Gag. AIDS Rev. 2007, 9 (3): 150-161.","journal-title":"AIDS Rev"},{"issue":"6504","key":"1026_CR5","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/372363a0","volume":"372","author":"M Thali","year":"1994","unstructured":"Thali M, Bukovsky A, Kondo E, Rosenwirth B, Walsh CT, Sodroski J, Gottlinger HG: Functional association of cyclophilin A with HIV-1 virions. Nature. 1994, 372 (6504): 363-365. 10.1038\/372363a0.","journal-title":"Nature"},{"issue":"6504","key":"1026_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/372359a0","volume":"372","author":"EK Franke","year":"1994","unstructured":"Franke EK, Yuan HE, Luban J: Specific incorporation of cyclophilin A into HIV-1 virions. Nature. 1994, 372 (6504): 359-362. 10.1038\/372359a0.","journal-title":"Nature"},{"issue":"29","key":"1026_CR7","doi-asserted-by":"publisher","first-page":"10774","DOI":"10.1073\/pnas.0402361101","volume":"101","author":"T Hatziioannou","year":"2004","unstructured":"Hatziioannou T, Perez-Caballero D, Yang A, Cowan S, Bieniasz PD: Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc Natl Acad Sci USA. 2004, 101 (29): 10774-10779. 10.1073\/pnas.0402361101.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"1026_CR8","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/nm910","volume":"9","author":"GJ Towers","year":"2003","unstructured":"Towers GJ, Hatziioannou T, Cowan S, Goff SP, Luban J, Bieniasz PD: Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nat Med. 2003, 9 (9): 1138-1143. 10.1038\/nm910.","journal-title":"Nat Med"},{"issue":"3","key":"1026_CR9","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1073\/pnas.0337541100","volume":"100","author":"NA Kootstra","year":"2003","unstructured":"Kootstra NA, Munk C, Tonnu N, Landau NR, Verma IM: Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells. Proc Natl Acad Sci USA. 2003, 100 (3): 1298-1303. 10.1073\/pnas.0337541100.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"23","key":"1026_CR10","doi-asserted-by":"publisher","first-page":"12800","DOI":"10.1128\/JVI.78.23.12800-12808.2004","volume":"78","author":"E Sokolskaja","year":"2004","unstructured":"Sokolskaja E, Sayah DM, Luban J: Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity. J Virol. 2004, 78 (23): 12800-12808. 10.1128\/JVI.78.23.12800-12808.2004.","journal-title":"J Virol"},{"issue":"1","key":"1026_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1128\/JVI.79.1.176-183.2005","volume":"79","author":"T Hatziioannou","year":"2005","unstructured":"Hatziioannou T, Perez-Caballero D, Cowan S, Bieniasz PD: Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells. J Virol. 2005, 79 (1): 176-183. 10.1128\/JVI.79.1.176-183.2005.","journal-title":"J Virol"},{"issue":"6","key":"1026_CR12","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1128\/JVI.80.6.2855-2862.2006","volume":"80","author":"E Sokolskaja","year":"2006","unstructured":"Sokolskaja E, Berthoux L, Luban J: Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells. J Virol. 2006, 80 (6): 2855-2862. 10.1128\/JVI.80.6.2855-2862.2006.","journal-title":"J Virol"},{"issue":"10","key":"1026_CR13","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1128\/JVI.80.10.4683-4690.2006","volume":"80","author":"Z Keckesova","year":"2006","unstructured":"Keckesova Z, Ylinen LM, Towers GJ: Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5 alpha antiviral activity. J Virol. 2006, 80 (10): 4683-4690. 10.1128\/JVI.80.10.4683-4690.2006.","journal-title":"J Virol"},{"issue":"6","key":"1026_CR14","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1093\/emboj\/20.6.1300","volume":"20","author":"D Braaten","year":"2001","unstructured":"Braaten D, Luban J: Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells. Embo J. 2001, 20 (6): 1300-1309. 10.1093\/emboj\/20.6.1300.","journal-title":"Embo J"},{"issue":"1","key":"1026_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1006\/viro.1996.0421","volume":"222","author":"EK Franke","year":"1996","unstructured":"Franke EK, Luban J: Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction. Virology. 1996, 222 (1): 279-282. 10.1006\/viro.1996.0421.","journal-title":"Virology"},{"issue":"6","key":"1026_CR16","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1128\/jvi.70.6.3536-3544.1996","volume":"70","author":"C Aberham","year":"1996","unstructured":"Aberham C, Weber S, Phares W: Spontaneous mutations in the human immunodeficiency virus type 1 gag gene that affect viral replication in the presence of cyclosporins. J Virol. 1996, 70 (6): 3536-3544.","journal-title":"J Virol"},{"issue":"8","key":"1026_CR17","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1128\/jvi.70.8.5170-5176.1996","volume":"70","author":"D Braaten","year":"1996","unstructured":"Braaten D, Aberham C, Franke EK, Yin L, Phares W, Luban J: Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A. J Virol. 1996, 70 (8): 5170-5176.","journal-title":"J Virol"},{"issue":"8","key":"1026_CR18","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1128\/JVI.02634-06","volume":"81","author":"R Yang","year":"2007","unstructured":"Yang R, Aiken C: A mutation in alpha helix 3 of CA renders human immunodeficiency virus type 1 cyclosporin A resistant and dependent: rescue by a second-site substitution in a distal region of CA. J Virol. 2007, 81 (8): 3749-3756. 10.1128\/JVI.02634-06.","journal-title":"J Virol"},{"issue":"7","key":"1026_CR19","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0092-8674(00)81823-1","volume":"87","author":"TR Gamble","year":"1996","unstructured":"Gamble TR, Vajdos FF, Yoo S, Worthylake DK, Houseweart M, Sundquist WI, Hill CP: Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell. 1996, 87 (7): 1285-1294. 10.1016\/S0092-8674(00)81823-1.","journal-title":"Cell"},{"issue":"5339","key":"1026_CR20","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1126\/science.278.5339.849","volume":"278","author":"TR Gamble","year":"1997","unstructured":"Gamble TR, Yoo S, Vajdos FF, von Schwedler UK, Worthylake DK, Wang H, McCutcheon JP, Sundquist WI, Hill CP: Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science. 1997, 278 (5339): 849-853. 10.1126\/science.278.5339.849.","journal-title":"Science"},{"issue":"2","key":"1026_CR21","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1074\/jbc.M505920200","volume":"281","author":"H Gatanaga","year":"2006","unstructured":"Gatanaga H, Das D, Suzuki Y, Yeh DD, Hussain KA, Ghosh AK, Mitsuya H: Altered HIV-1 Gag protein interactions with cyclophilin A (CypA) on the acquisition of H219Q and H219P substitutions in the CypA binding loop. J Biol Chem. 2006, 281 (2): 1241-1250. 10.1074\/jbc.M505920200.","journal-title":"J Biol Chem"},{"issue":"3","key":"1026_CR22","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1128\/JVI.01519-06","volume":"81","author":"J Luban","year":"2007","unstructured":"Luban J: Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection. J Virol. 2007, 81 (3): 1054-1061. 10.1128\/JVI.01519-06.","journal-title":"J Virol"},{"key":"1026_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1742-4690-4-40","volume":"4","author":"GJ Towers","year":"2007","unstructured":"Towers GJ: The control of viral infection by tripartite motif proteins and cyclophilin A. Retrovirology. 2007, 4: 40-10.1186\/1742-4690-4-40.","journal-title":"Retrovirology"},{"issue":"11","key":"1026_CR24","doi-asserted-by":"publisher","first-page":"6005","DOI":"10.1128\/JVI.78.11.6005-6012.2004","volume":"78","author":"T Hatziioannou","year":"2004","unstructured":"Hatziioannou T, Cowan S, Von Schwedler UK, Sundquist WI, Bieniasz PD: Species-specific tropism determinants in the human immunodeficiency virus type 1 capsid. J Virol. 2004, 78 (11): 6005-6012. 10.1128\/JVI.78.11.6005-6012.2004.","journal-title":"J Virol"},{"issue":"18","key":"1026_CR25","doi-asserted-by":"publisher","first-page":"11914","DOI":"10.1073\/pnas.162299499","volume":"99","author":"S Cowan","year":"2002","unstructured":"Cowan S, Hatziioannou T, Cunningham T, Muesing MA, Gottlinger HG, Bieniasz PD: Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc Natl Acad Sci USA. 2002, 99 (18): 11914-11919. 10.1073\/pnas.162299499.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1026_CR26","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1128\/JVI.77.1.726-731.2003","volume":"77","author":"CM Owens","year":"2003","unstructured":"Owens CM, Yang PC, Gottlinger H, Sodroski J: Human and simian immunodeficiency virus capsid proteins are major viral determinants of early, postentry replication blocks in simian cells. J Virol. 2003, 77 (1): 726-731. 10.1128\/JVI.77.1.726-731.2003.","journal-title":"J Virol"},{"issue":"10","key":"1026_CR27","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.1128\/JVI.78.10.5423-5437.2004","volume":"78","author":"CM Owens","year":"2004","unstructured":"Owens CM, Song B, Perron MJ, Yang PC, Stremlau M, Sodroski J: Binding and susceptibility to postentry restriction factors in monkey cells are specified by distinct regions of the human immunodeficiency virus type 1 capsid. J Virol. 2004, 78 (10): 5423-5437. 10.1128\/JVI.78.10.5423-5437.2004.","journal-title":"J Virol"},{"issue":"22","key":"1026_CR28","doi-asserted-by":"publisher","first-page":"12295","DOI":"10.1073\/pnas.200286297","volume":"97","author":"G Towers","year":"2000","unstructured":"Towers G, Bock M, Martin S, Takeuchi Y, Stoye JP, Danos O: A conserved mechanism of retrovirus restriction in mammals. Proc Natl Acad Sci USA. 2000, 97 (22): 12295-12299. 10.1073\/pnas.200286297.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6977","key":"1026_CR29","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nature02343","volume":"427","author":"M Stremlau","year":"2004","unstructured":"Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J: The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature. 2004, 427 (6977): 848-853. 10.1038\/nature02343.","journal-title":"Nature"},{"issue":"14","key":"1026_CR30","doi-asserted-by":"publisher","first-page":"5514","DOI":"10.1073\/pnas.0509996103","volume":"103","author":"M Stremlau","year":"2006","unstructured":"Stremlau M, Perron M, Lee M, Li Y, Song B, Javanbakht H, Diaz-Griffero F, Anderson DJ, Sundquist WI, Sodroski J: Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc Natl Acad Sci USA. 2006, 103 (14): 5514-5519. 10.1073\/pnas.0509996103.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"15","key":"1026_CR31","doi-asserted-by":"publisher","first-page":"9410","DOI":"10.1128\/JVI.79.15.9410-9418.2005","volume":"79","author":"D Marchant","year":"2005","unstructured":"Marchant D, Neil SJ, Aubin K, Schmitz C, McKnight A: An envelope-determined, pH-independent endocytic route of viral entry determines the susceptibility of human immunodeficiency virus type 1 (HIV-1) and HIV-2 to Lv2 restriction. J Virol. 2005, 79 (15): 9410-9418. 10.1128\/JVI.79.15.9410-9418.2005.","journal-title":"J Virol"},{"issue":"1","key":"1026_CR32","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.virol.2004.11.025","volume":"332","author":"S Reuter","year":"2005","unstructured":"Reuter S, Kaumanns P, Buschhorn SB, Dittmar MT: Role of HIV-2 envelope in Lv2-mediated restriction. Virology. 2005, 332 (1): 347-358. 10.1016\/j.virol.2004.11.025.","journal-title":"Virology"},{"issue":"4","key":"1026_CR33","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1128\/JVI.78.4.2006-2016.2004","volume":"78","author":"C Schmitz","year":"2004","unstructured":"Schmitz C, Marchant D, Neil SJ, Aubin K, Reuter S, Dittmar MT, McKnight A: Lv2, a novel postentry restriction, is mediated by both capsid and envelope. J Virol. 2004, 78 (4): 2006-2016. 10.1128\/JVI.78.4.2006-2016.2004.","journal-title":"J Virol"},{"issue":"29","key":"1026_CR34","doi-asserted-by":"publisher","first-page":"10780","DOI":"10.1073\/pnas.0402474101","volume":"101","author":"Z Keckesova","year":"2004","unstructured":"Keckesova Z, Ylinen LM, Towers GJ: The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc Natl Acad Sci USA. 2004, 101 (29): 10780-10785. 10.1073\/pnas.0402474101.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"32","key":"1026_CR35","doi-asserted-by":"publisher","first-page":"11827","DOI":"10.1073\/pnas.0403364101","volume":"101","author":"MJ Perron","year":"2004","unstructured":"Perron MJ, Stremlau M, Song B, Ulm W, Mulligan RC, Sodroski J: TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc Natl Acad Sci USA. 2004, 101 (32): 11827-11832. 10.1073\/pnas.0403364101.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"29","key":"1026_CR36","doi-asserted-by":"publisher","first-page":"10786","DOI":"10.1073\/pnas.0402876101","volume":"101","author":"MW Yap","year":"2004","unstructured":"Yap MW, Nisole S, Lynch C, Stoye JP: Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc Natl Acad Sci USA. 2004, 101 (29): 10786-10791. 10.1073\/pnas.0402876101.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"24","key":"1026_CR37","doi-asserted-by":"publisher","first-page":"15175","DOI":"10.1128\/JVI.79.24.15175-15188.2005","volume":"79","author":"DT Saenz","year":"2005","unstructured":"Saenz DT, Teo W, Olsen JC, Poeschla EM: Restriction of feline immunodeficiency virus by Ref1, Lv1, and primate TRIM5alpha proteins. J Virol. 2005, 79 (24): 15175-15188. 10.1128\/JVI.79.24.15175-15188.2005.","journal-title":"J Virol"},{"issue":"18","key":"1026_CR38","doi-asserted-by":"publisher","first-page":"11580","DOI":"10.1128\/JVI.79.18.11580-11587.2005","volume":"79","author":"LM Ylinen","year":"2005","unstructured":"Ylinen LM, Keckesova Z, Wilson SJ, Ranasinghe S, Towers GJ: Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5alpha alleles. J Virol. 2005, 79 (18): 11580-11587. 10.1128\/JVI.79.18.11580-11587.2005.","journal-title":"J Virol"},{"issue":"2","key":"1026_CR39","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.virol.2006.05.035","volume":"353","author":"F Zhang","year":"2006","unstructured":"Zhang F, Hatziioannou T, Perez-Caballero D, Derse D, Bieniasz PD: Antiretroviral potential of human tripartite motif-5 and related proteins. Virology. 2006, 353 (2): 396-409. 10.1016\/j.virol.2006.05.035.","journal-title":"Virology"},{"issue":"10","key":"1026_CR40","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nrmicro1248","volume":"3","author":"S Nisole","year":"2005","unstructured":"Nisole S, Stoye JP, Saib A: TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol. 2005, 3 (10): 799-808. 10.1038\/nrmicro1248.","journal-title":"Nat Rev Microbiol"},{"issue":"13","key":"1026_CR41","doi-asserted-by":"publisher","first-page":"6772","DOI":"10.1128\/JVI.00410-08","volume":"82","author":"Z Kratovac","year":"2008","unstructured":"Kratovac Z, Virgen CA, Bibollet-Ruche F, Hahn BH, Bieniasz PD, Hatziioannou T: Primate lentivirus capsid sensitivity to TRIM5 proteins. J Virol. 2008, 82 (13): 6772-6777. 10.1128\/JVI.00410-08.","journal-title":"J Virol"},{"issue":"21","key":"1026_CR42","doi-asserted-by":"publisher","first-page":"11816","DOI":"10.1128\/JVI.78.21.11816-11822.2004","volume":"78","author":"Y Ikeda","year":"2004","unstructured":"Ikeda Y, Ylinen LM, Kahar-Bador M, Towers GJ: Influence of gag on human immunodeficiency virus type 1 species-specific tropism. J Virol. 2004, 78 (21): 11816-11822. 10.1128\/JVI.78.21.11816-11822.2004.","journal-title":"J Virol"},{"issue":"48","key":"1026_CR43","doi-asserted-by":"publisher","first-page":"40293","DOI":"10.1074\/jbc.M506314200","volume":"280","author":"U Chatterji","year":"2005","unstructured":"Chatterji U, Bobardt MD, Stanfield R, Ptak RG, Pallansch LA, Ward PA, Jones MJ, Stoddart CA, Scalfaro P, Dumont JM, Besseghir K, Rosenwirth B, Gallay PA: Naturally occurring capsid substitutions render HIV-1 cyclophilin A independent in human cells and TRIM-cyclophilin-resistant in Owl monkey cells. J Biol Chem. 2005, 280 (48): 40293-40300. 10.1074\/jbc.M506314200.","journal-title":"J Biol Chem"},{"issue":"15","key":"1026_CR44","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1097\/QAD.0b013e3282effa87","volume":"21","author":"NA Kootstra","year":"2007","unstructured":"Kootstra NA, Navis M, Beugeling C, van Dort KA, Schuitemaker H: The presence of the Trim5alpha escape mutation H87Q in the capsid of late stage HIV-1 variants is preceded by a prolonged asymptomatic infection phase. Aids. 2007, 21 (15): 2015-2023.","journal-title":"Aids"},{"issue":"22","key":"1026_CR45","doi-asserted-by":"publisher","first-page":"12608","DOI":"10.1128\/JVI.01369-07","volume":"81","author":"MA Brockman","year":"2007","unstructured":"Brockman MA, Schneidewind A, Lahaie M, Schmidt A, Miura T, Desouza I, Ryvkin F, Derdeyn CA, Allen S, Hunter E, Mulenga J, Goepfert PA, Walker BD, Allen TM: Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. J Virol. 2007, 81 (22): 12608-12618. 10.1128\/JVI.01369-07.","journal-title":"J Virol"},{"issue":"22","key":"1026_CR46","doi-asserted-by":"publisher","first-page":"12382","DOI":"10.1128\/JVI.01543-07","volume":"81","author":"A Schneidewind","year":"2007","unstructured":"Schneidewind A, Brockman MA, Yang R, Adam RI, Li B, Le Gall S, Rinaldo CR, Craggs SL, Allgaier RL, Power KA, Kuntzen T, Tung CS, LaBute MX, Mueller SM, Harrer T, McMichael AJ, Goulder PJ, Aiken C, Brander C, Kelleher AD, Allen TM: Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J Virol. 2007, 81 (22): 12382-12393. 10.1128\/JVI.01543-07.","journal-title":"J Virol"},{"issue":"5","key":"1026_CR47","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1084\/jem.20080569","volume":"205","author":"TM Allen","year":"2008","unstructured":"Allen TM, Altfeld M: Crippling HIV one mutation at a time. J Exp Med. 2008, 205 (5): 1003-1007. 10.1084\/jem.20080569.","journal-title":"J Exp Med"},{"issue":"1","key":"1026_CR48","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/JVI.72.1.303-308.1998","volume":"72","author":"B Ackerson","year":"1998","unstructured":"Ackerson B, Rey O, Canon J, Krogstad P: Cells with high cyclophilin A content support replication of human immunodeficiency virus type 1 Gag mutants with decreased ability to incorporate cyclophilin A. J Virol. 1998, 72 (1): 303-308.","journal-title":"J Virol"},{"issue":"8","key":"1026_CR49","doi-asserted-by":"crossref","first-page":"6430","DOI":"10.1128\/JVI.72.8.6430-6436.1998","volume":"72","author":"L Yin","year":"1998","unstructured":"Yin L, Braaten D, Luban J: Human immunodeficiency virus type 1 replication is modulated by host cyclophilin A expression levels. J Virol. 1998, 72 (8): 6430-6436.","journal-title":"J Virol"},{"issue":"4","key":"1026_CR50","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1128\/JVI.01876-08","volume":"83","author":"LM Ylinen","year":"2009","unstructured":"Ylinen LM, Schaller T, Price A, Fletcher AJ, Noursadeghi M, James LC, Towers GJ: Cyclophilin A levels dictate infection efficiency of human immunodeficiency virus type 1 capsid escape mutants A92E and G94D. J Virol. 2009, 83 (4): 2044-2047. 10.1128\/JVI.01876-08.","journal-title":"J Virol"},{"issue":"5","key":"1026_CR51","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nm1562","volume":"13","author":"R Sakuma","year":"2007","unstructured":"Sakuma R, Noser JA, Ohmine S, Ikeda Y: Rhesus monkey TRIM5alpha restricts HIV-1 production through rapid degradation of viral Gag polyproteins. Nat Med. 2007, 13 (5): 631-635. 10.1038\/nm1562.","journal-title":"Nat Med"},{"issue":"3","key":"1026_CR52","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nm0308-235","volume":"14","author":"F Zhang","year":"2008","unstructured":"Zhang F, Perez-Caballero D, Hatziioannou T, Bieniasz PD: No effect of endogenous TRIM5alpha on HIV-1 production. Nat Med. 2008, 14 (3): 235-236. 10.1038\/nm0308-235.","journal-title":"Nat Med"},{"issue":"6","key":"1026_CR53","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1128\/jvi.70.6.3551-3560.1996","volume":"70","author":"D Braaten","year":"1996","unstructured":"Braaten D, Franke EK, Luban J: Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J Virol. 1996, 70 (6): 3551-3560.","journal-title":"J Virol"},{"issue":"2","key":"1026_CR54","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1006\/viro.2001.1347","volume":"294","author":"K Wiegers","year":"2002","unstructured":"Wiegers K, Krausslich HG: Differential dependence of the infectivity of HIV-1 group O isolates on the cellular protein cyclophilin A. Virology. 2002, 294 (2): 289-295. 10.1006\/viro.2001.1347.","journal-title":"Virology"},{"issue":"4","key":"1026_CR55","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1128\/AAC.01324-07","volume":"52","author":"RG Ptak","year":"2008","unstructured":"Ptak RG, Gallay PA, Jochmans D, Halestrap AP, Ruegg UT, Pallansch LA, Bobardt MD, de B\u00e9thune MP, Neyts J, De Clercq E, Dumont JM, Scalfaro P, Besseghir K, Wenger RM, Rosenwirth B: Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent. Antimicrob Agents Chemother. 2008, 52 (4): 1302-1317. 10.1128\/AAC.01324-07.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"1026_CR56","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1128\/JVI.79.5.3139-3145.2005","volume":"79","author":"M Stremlau","year":"2005","unstructured":"Stremlau M, Perron M, Welikala S, Sodroski J: Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction. J Virol. 2005, 79 (5): 3139-3145. 10.1128\/JVI.79.5.3139-3145.2005.","journal-title":"J Virol"},{"issue":"1","key":"1026_CR57","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.virol.2006.03.015","volume":"351","author":"M Stremlau","year":"2006","unstructured":"Stremlau M, Song B, Javanbakht H, Perron M, Sodroski J: Cyclophilin A: an auxiliary but not necessary cofactor for TRIM5alpha restriction of HIV-1. Virology. 2006, 351 (1): 112-120. 10.1016\/j.virol.2006.03.015.","journal-title":"Virology"},{"issue":"41","key":"1026_CR58","doi-asserted-by":"publisher","first-page":"14849","DOI":"10.1073\/pnas.0505659102","volume":"102","author":"L Berthoux","year":"2005","unstructured":"Berthoux L, Sebastian S, Sokolskaja E, Luban J: Cyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cells. Proc Natl Acad Sci USA. 2005, 102 (41): 14849-14853. 10.1073\/pnas.0505659102.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1026_CR59","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1742-4690-5-23","volume":"5","author":"T Nora","year":"2008","unstructured":"Nora T, Bouchonnet F, Labrosse B, Charpentier C, Mammano F, Clavel F, Hance AJ: Functional diversity of HIV-1 envelope proteins expressed by contemporaneous plasma viruses. Retrovirology. 2008, 5: 23-10.1186\/1742-4690-5-23.","journal-title":"Retrovirology"},{"issue":"4","key":"1026_CR60","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1128\/JVI.72.4.3300-3306.1998","volume":"72","author":"V Zennou","year":"1998","unstructured":"Zennou V, Mammano F, Paulous S, Mathez D, Clavel F: Loss of viral fitness associated with multiple Gag and Gag-Pol processing defects in human immunodeficiency virus type 1 variants selected for resistance to protease inhibitors in vivo. J Virol. 1998, 72 (4): 3300-3306.","journal-title":"J Virol"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4690-6-21.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T07:24:12Z","timestamp":1630481052000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/1742-4690-6-21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,2]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["1026"],"URL":"https:\/\/doi.org\/10.1186\/1742-4690-6-21","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,2]]},"assertion":[{"value":"9 January 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"21"}}